Medtronic Total Liabilities decreased by 0.5% to $42.29B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.8%, from $40.36B to $42.29B. Over 4 years (FY 2021 to FY 2025), Total Liabilities shows relatively stable performance with a 1.2% CAGR.
A high level of total liabilities relative to equity indicates a more leveraged capital structure and higher financial risk.
The aggregate of all current and non-current debts and obligations owed by the company to external parties. It represent...
Analyzed alongside Total Assets to determine the Debt-to-Asset ratio, which is a standard measure of solvency across all industries.
total_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $40.14B | $39.60B | $39.09B | $38.26B | $37.07B | $41.18B | $42.52B | $39.28B | $39.41B | $38.44B | $38.84B | $39.56B | $41.59B | $41.33B | $40.36B | $43.42B | $42.84B | $42.49B | $42.29B |
| QoQ Change | — | -1.3% | -1.3% | -2.1% | -3.1% | +11.1% | +3.2% | -7.6% | +0.3% | -2.5% | +1.0% | +1.9% | +5.1% | -0.6% | -2.3% | +7.6% | -1.3% | -0.8% | -0.5% |
| YoY Change | — | — | — | — | -7.6% | +4.0% | +8.8% | +2.7% | +6.3% | -6.7% | -8.6% | +0.7% | +5.5% | +7.5% | +3.9% | +9.8% | +3.0% | +2.8% | +4.8% |